A Study of Epacadostat in Combination With Pembrolizumab and Chemotherapy in Participants With Advanced or Metastatic Solid Tumors (ECHO-207/KEYNOTE-723)
Clinical trial NCT03085914 · COMPLETED
Trial details
- NCT number
- NCT03085914
- Sponsor
- Incyte Corporation
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-02
- Primary completion
- 2019-01-25
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.